Advertisement

Alcyone Lifesciences, Inc., which is developing technology to help neurosurgeons treat conditions in the central nervous system, has raised a $1.8 million Series A round out of a $2 million offering, according to founder and CEO P.J. Anand.

SOURCE

Advertisement
Advertisement